Slay Sarcoma Research Initiative
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2015 | 0 | 0 | 0 | — | — |
| 2016 | 48,584 | 1,183 | 47,401 | 480.8 | — |
| 2017 | 98,418 | 47,250 | 51,168 | 25.0 | — |
| 2018 | 41,771 | 100,834 | −59,063 | 4.7 | — |
| 2019 | 49,150 | 42,259 | 6,891 | 13.2 | — |
| 2020 | 5,600 | 42,964 | −37,364 | 2.5 | — |
| 2021 | 32,895 | 36,837 | −3,942 | 1.7 | — |
| 2022 | 45,031 | 44,583 | 448 | 1.5 | — |
| 2023 | 48,848 | 51,999 | −3,151 | 0.5 | — |
In its most recent public year (2023), this organization spent $3,151 more than it brought in. Its reserves stood at about 0.5 months of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Slay Sarcoma Research Initiative's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works